These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20113909)

  • 1. Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia.
    Todd NW; Lavania S; Park MH; Iacono AT; Franks TJ; Galvin JR; Jeudy J; Britt EJ; Luzina IG; Hasday JD; Atamas SP
    J Heart Lung Transplant; 2010 Feb; 29(2):188-94. PubMed ID: 20113909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Retrospective Analysis of Interstitial Lung Disease Patients Associated with Pulmonary Hypertension.
    Lv H; Liu J; Pan Q; Cai R; Zhang J
    Med Sci Monit; 2019 Oct; 25():7763-7769. PubMed ID: 31618191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in interstitial lung disease.
    Nathan SD
    Int J Clin Pract Suppl; 2008 Jul; (160):21-8. PubMed ID: 18720579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model.
    Ruocco G; Cekorja B; Rottoli P; Refini RM; Pellegrini M; Di Tommaso C; Del Castillo G; Franci B; Nuti R; Palazzuoli A
    Respir Med; 2015 Mar; 109(3):406-15. PubMed ID: 25613108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias: comparison between idiopathic and collagen vascular disease associated interstitial pneumonias.
    Handa T; Nagai S; Miki S; Ueda S; Yukawa N; Fushimi Y; Ito Y; Ohta K; Mimori T; Mishima M; Izumi T
    Intern Med; 2007; 46(12):831-7. PubMed ID: 17575374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.
    Suzuki A; Taniguchi H; Watanabe N; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Nishiyama O; Hasegawa Y
    PLoS One; 2014; 9(9):e108339. PubMed ID: 25268705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.
    Lettieri CJ; Nathan SD; Barnett SD; Ahmad S; Shorr AF
    Chest; 2006 Mar; 129(3):746-52. PubMed ID: 16537877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
    Lupi-Herrera E; Santos-Martínez LE; Pulido T; Sandoval J
    Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation.
    Nowak J; Hudzik B; Jastrzȩbski D; Niedziela JT; Rozentryt P; Wojarski J; Ochman M; Karolak W; Żegleń S; Gierlotka M; Gąsior M
    Clin Respir J; 2018 Mar; 12(3):930-938. PubMed ID: 28052583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension.
    Simonson JL; Pandya D; Khan S; Verma S; Greenberg HE; Talwar A
    Sleep Breath; 2022 Dec; 26(4):1711-1715. PubMed ID: 34993759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
    Awerbach JD; Stackhouse KA; Lee J; Dahhan T; Parikh KS; Krasuski RA
    Respir Med; 2019 Apr; 150():126-130. PubMed ID: 30961938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment for pulmonary hypertension in interstitial lung disease.
    Chan RK; Horrigan M; Goh NSL; Khor YH
    Intern Med J; 2023 Aug; 53(8):1415-1422. PubMed ID: 35848362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.
    Nemoto K; Oh-Ishi S; Akiyama T; Yabuuchi Y; Goto H; Nonaka M; Sasatani Y; Tachi H; Arai N; Ishikawa H; Hyodo K; Hase I; Miura Y; Takaku T; Hayashihara K; Saito T
    BMC Pulm Med; 2019 Sep; 19(1):167. PubMed ID: 31477076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Pulmonary Hypertension on Intrahospital Mortality in Lung Transplantation for Interstitial Lung Disease.
    Corral-Blanco M; Prudencio-Ribera VC; Jarrín-Estupiñán ME; Alonso-Moralejo R; Pérez-González V; Meneses-Pardo JC; Hermira-Anchuelo A; De Pablo-Gafas A
    Transplant Proc; 2019 Mar; 51(2):380-382. PubMed ID: 30879546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.